Mainz Biomed BV (MYNZ)
$5.36 $0.36 (6.89%) 4:38 PM 12/13/24
NASDAQ | $USD | Diagnostics & ResearchStock Data
-
Market Cap
$13.96M -
Day's Range
$4.58 - $5.72 -
Volume
1,959,578 -
52 Week Low / High
$0.18 - $7.95 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 0
- Strong Buy
- 1
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $9.67
- Target Price
Company News
-
The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024
The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...
-
The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024
The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...
-
The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024
The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...
-
The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024
The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...
-
The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024
The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...
-
The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024
The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...
-
The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024
The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...
-
The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024
The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...
Similar Stocks
Portfolio
Comprised of 1 portfolios